Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folliculi sennae ethanol extract is a plant-derived extract obtained from the pods (fruit) of the Senna plant (typically *Senna alexandrina*). While Senna is traditionally known for its laxative properties due to sennosides, this specific ethanol extract has been investigated for its multifunctional potential in treating Alzheimer's disease and type 2 diabetes mellitus. It contains bioactive phenolic compounds such as quercetin, luteolin, kaempferol, and gallic acid. The extract demonstrates antioxidant activity and acts as an inhibitor of key enzymes including acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glucosidase. By modulating oxidative stress and inhibiting these enzymes, it aims to provide neuroprotective and glucose-regulating effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folliculi sennae ethanol extract.